Evidence map›Paper›PMID 39622903›Full record

ArticleScientific reports2024

A feasibility study using quantitative and interpretable histological analyses of celiac disease for automated cell type and tissue area classification.

Michael Griffin, Aaron M Gruver, Chintan Shah, Qasim Wani, Darren Fahy, Archit Khosla, Christian Kirkup, Daniel Borders, Jacqueline A Brosnan-Cashman, Angie D Fulford and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Michael GriffinPathAI, Inc., 1325 Boylston Street, Suite 10000, Boston, MA, 02215, USA.
Aaron M GruverEli Lilly and Company, Indianapolis, IN, USA.
Chintan ShahPathAI, Inc., 1325 Boylston Street, Suite 10000, Boston, MA, 02215, USA.
Qasim WaniPathAI, Inc., 1325 Boylston Street, Suite 10000, Boston, MA, 02215, USA.
Darren FahyPathAI, Inc., 1325 Boylston Street, Suite 10000, Boston, MA, 02215, USA.
Archit KhoslaPathAI, Inc., 1325 Boylston Street, Suite 10000, Boston, MA, 02215, USA.
Christian KirkupPathAI, Inc., 1325 Boylston Street, Suite 10000, Boston, MA, 02215, USA.
Daniel BordersPathAI, Inc., 1325 Boylston Street, Suite 10000, Boston, MA, 02215, USA.
Jacqueline A Brosnan-CashmanPathAI, Inc., 1325 Boylston Street, Suite 10000, Boston, MA, 02215, USA.
Angie D FulfordEli Lilly and Company, Indianapolis, IN, USA.
Kelly M CredilleEli Lilly and Company, Indianapolis, IN, USA.
Christina JaysonPathAI, Inc., 1325 Boylston Street, Suite 10000, Boston, MA, 02215, USA.
Fedaa Najdawi *PathAI, Inc., 1325 Boylston Street, Suite 10000, Boston, MA, 02215, USA. fedaa.najdawi@pathai.com.ORCID 0000-0002-2818-8354
Klaus Gottlieb *Eli Lilly and Company, Indianapolis, IN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histological assessment is essential for the diagnosis and management of celiac disease. Current scoring systems, including modified Marsh (Marsh-Oberhuber) score, lack inter-pathologist agreement. To address this unmet need, we aimed to develop a fully automated, quantitative approach for histology characterisation of celiac disease. Convolutional neural network models were trained using pathologist annotations of hematoxylin and eosin-stained biopsies of celiac disease mucosa and normal duodenum to identify cells, tissue and artifact regions. Biopsies of duodenal mucosa of varying celiac disease severity, and normal duodenum were collected from a large central laboratory. Celiac disease slides (N = 318) were split into training (n = 230; 72.3%), validation (n = 60; 18.9%) and test (n = 28; 8.8%) datasets. Normal duodenum slides (N = 58) were similarly divided into training (n = 40; 69.0%), validation (n = 12; 20.7%) and test (n = 6; 10.3%) datasets. Human interpretable features were extracted and the strength of their correlation with Marsh scores were calculated using Spearman rank correlations. Our model identified cells, tissue regions and artifacts, including distinguishing intraepithelial lymphocytes and differentiating villous epithelium from crypt epithelium. Proportional area measurements representing villous atrophy negatively correlated with Marsh scores (r =  - 0.79), while measurements indicative of crypt hyperplasia positively correlated (r = 0.71). Furthermore, features distinguishing celiac disease from normal duodenum were identified. Our novel model provides an explainable and fully automated approach for histology characterisation of celiac disease that correlates with modified Marsh scores, potentially facilitating diagnosis, prognosis, clinical trials and treatment response monitoring.

Indexed as

Celiac DiseaseDuodenumFeasibility StudiesIntestinal MucosaAdolescentAdultBiopsyChildFemaleHumansMaleMiddle AgedNeural Networks, ComputerArtificial intelligenceCeliac diseaseHistologyMachine learning

Identifiers

PMID39622903
PMCPMC11612272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.